Availability of drugs, biological products, and devices

410 ILCS 649/15, under Right to Try Act.

410 ILCS 649/15

(410 ILCS 649/15)

    Sec. 15. Availability of drugs, biological products, and devices.     (a) A manufacturer of an investigational drug, biological product, or device may make available such drug, product, or device to eligible patients. Nothing in this Act shall be construed to require a manufacturer to make available any drug, product, or device.     (b) A manufacturer may:         (1) provide an investigational drug, biological     product, or device to an eligible patient without receiving compensation; or        (2) require an eligible patient to pay the costs of     or associated with the manufacture of the investigational drug, biological product, or device. (Source: P.A. 99-270, eff. 1-1-16.)